Description
Seeking adults with early stage triple negative breast cancer for a study comparing a shorter chemo-immunotherapy to the usual therapy.
Overview
Participants in this study will be randomly assigned to get either chemo-immunotherapy for up to 6 cycles or the usual chemo-immunotherapy for 8 cycles before having the usual surgery and post-surgery treatment.
What we're hoping for
We are studying if a shorter chemo-immunotherapy is better, worse, or the same as the usual chemo-immunotherapy before surgery and post-surgery treatment for adults with early stage triple negative breast cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT05929768